BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3490841)

  • 1. Effect of reserpine on regional cerebral glucose metabolism in control and migraine subjects.
    Sachs H; Wolf A; Russell JA; Christman DR
    Arch Neurol; 1986 Nov; 43(11):1117-23. PubMed ID: 3490841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positron emission tomography and migraine].
    Chabriat H
    Pathol Biol (Paris); 1992 Apr; 40(4):344-8. PubMed ID: 1495819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of regional cerebral glucose metabolic rate in non-Korsakoff chronic alcoholism.
    Sachs H; Russell JA; Christman DR; Cook B
    Arch Neurol; 1987 Dec; 44(12):1242-51. PubMed ID: 3314816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography study of regional cerebral metabolism during general anesthesia with xenon in humans.
    Rex S; Schaefer W; Meyer PH; Rossaint R; Boy C; Setani K; Büll U; Baumert JH
    Anesthesiology; 2006 Nov; 105(5):936-43. PubMed ID: 17065887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional glucose metabolic rates in the human brain: a PET study.
    Gulyás B; Trón L; Balkay L; Emri M; Molnár T; Tóth G; Marian T
    Acta Biol Hung; 1996; 47(1-4):157-72. PubMed ID: 9123988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral metabolism of glucose in comatose and vegetative state patients.
    Tommasino C; Grana C; Lucignani G; Torri G; Fazio F
    J Neurosurg Anesthesiol; 1995 Apr; 7(2):109-16. PubMed ID: 7772963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load.
    Derache N; Marié RM; Constans JM; Defer GL
    J Neurol Sci; 2006 Jun; 245(1-2):103-9. PubMed ID: 16647086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients.
    Di W; Shi X; Zhu Y; Tao Y; Qi W; Luo N; Xiao Z; Yi C; Miao J; Zhang A; Zhang X; Fang Y
    Eur J Neurol; 2013 Apr; 20(4):655-62. PubMed ID: 23114018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study.
    Kim JH; Kim S; Suh SI; Koh SB; Park KW; Oh K
    Cephalalgia; 2010 Jan; 30(1):53-61. PubMed ID: 19489887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting brain glucose uptake in headache-free migraineurs.
    Kassab M; Bakhtar O; Wack D; Bednarczyk E
    Headache; 2009 Jan; 49(1):90-7. PubMed ID: 18657123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Chronological changes in the cerebral blood flow and cerebral metabolic rate for glucose in the ischemic rabbit brain].
    Tenjin H; Imahori Y; Mizukawa N; Hirakawa K; Oki F; Fujii R
    Neurol Med Chir (Tokyo); 1989 Dec; 29(12):1085-92. PubMed ID: 2484186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
    Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
    Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
    J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of cerebral glucose metabolic measurements in resting human subjects.
    Bartlett EJ; Brodie JD; Wolf AP; Christman DR; Laska E; Meissner M
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):502-12. PubMed ID: 3260593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys.
    Asai M; Fujikawa A; Noda A; Miyoshi S; Matsuoka N; Nishimura S
    Ann Nucl Med; 2009 Dec; 23(10):877-82. PubMed ID: 19924379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain hypometabolism of glucose in bulimia nervosa.
    Delvenne V; Goldman S; Simon Y; De Maertelaer V; Lotstra F
    Int J Eat Disord; 1997 May; 21(4):313-20. PubMed ID: 9138041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
    Brooks DJ; Gibbs JS; Sharp P; Herold S; Turton DR; Luthra SK; Kohner EM; Bloom SR; Jones T
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):240-4. PubMed ID: 3485643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.